News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Company News

Cardinal Health Launches LTV® 1150 Ventilator for Home Use
New System Offers Easy Transition from Inpatient Ventilation to Home Care
DUBLIN, Ohio, October 3, 2007 Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, introduced today its Lap Top Ventilator 1150 (LTV®) at the Medtrade Conference and Exposition in Orlando. Representing a significant step in bringing advanced patient care to the home, the LTV® 1150 enables caregivers to support patients’ challenging ongoing ventilation needs outside a clinical setting.
The LTV 1150 reliably provides clinically sophisticated ventilation with alarms that are easy to understand for family members who provide ongoing care.  It features active controls and alarm settings that are illuminated for easy identification.  Patients receiving ventilatory support on the LTV® 1200 in the hospital easily transition to the LTV 1150, since the systems share a common interface and settings. A consistent and intuitive interface simplifies training, saves time and reduces the potential for errors.  The system features internal Positive End Expiratory Pressure (PEEP) and Spontaneous Breathing Trial (SBT) while maintaining the light weight and small dimensions of the LTV series.
This newest ventilator for the home environment also offers a quick and easy setup.  Presets allow the clinician to select the patient type, and the LTV 1150 automatically configures nominal ventilation settings for infant, pediatric or adult patients.
“Physicians, respiratory therapists, and home care providers have made the LTV Series the ventilator of choice for home care patients seeking true portability and a higher quality of life,” said Arie Cohen, Cardinal Health’s senior vice president and general manager of Respiratory – Alternate Care.  “The LTV ventilator was the first commercially available mechanical ventilator to offer sophisticated respiratory modalities in a laptop-size device.  A comprehensive line of patient circuits, accessories and options that meet the needs of both pediatric and adult patients complements this latest innovation.”

At 14.5 lbs (6.5 kg), the LTV Series ventilators are a fraction of the size of comparably equipped ventilators, offering home care customers greater mobility.  The hallmark LTV® Series ventilators are a result of the company’s dedication to offering products that provide better patient care and economic value for the healthcare provider. 
Cardinal Health Respiratory
With its recent acquisition of VIASYS Healthcare, Cardinal Health is the leader in developing and marketing systems for critical care and diagnostic use.  Its respiratory care ventilators are some of the most technologically advanced devices available, with precise computer controllers and a simple graphical user interface.  Advanced monitoring capabilities provide clinicians with critical information, such as automatic inflection point calculations and esophageal pressure monitoring.   VIASYS' respiratory diagnostic systems are used to diagnose and treat pulmonary disease and sleep disorders, provide exercise and nutritional assessments and measure pulmonary capacity.
About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an $87 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.  With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris® IV pumps, Pyxis® automated dispensing systems, MedMined™ electronic infection surveillance, VIASYS® respiratory care products and the CareFusion™ patient identification system.  The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents.  More information about the company may be found at

More Company News

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health


Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...


Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields